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Neuropsychiatric disorders, such as schizophrenia, mood disor-
ders, and dementias, produce huge medicinal and socioeconomic
burdens for patients and society, posing significant challenges to
clinical and preclinical researchers. For example, animal mod-
els of neuropsychiatric disorders allow more advanced phar-
macological, biochemical, immune-histochemical, electrophysi-
ological, and other techniques to be applied compared to cases
with human subjects. Therefore, preclinical investigations are
expected to provide valuable information for the development of
novel therapeutic options that may benefit patients with specific
disorders.
Disturbances of cognitive function, e.g., several types of mem-
ory, executive function, attention/information processing, and
fluency, are core symptoms of schizophrenia, Alzheimer’s dis-
ease (AD), obsessive-compulsive disorder (OCD), epilepsy, etc. In
fact, impaired cognition has been shown to negatively affect daily
function, sociability, and long-term outcome of patients.
The aim of this e-book is to provide cutting-edge knowledge
and reviews of cognitive deficits of neuropsychiatric diseases, in
relation to brain function, from a variety of standpoints.
Three intriguing papers (Zawadzki et al., 2013; Fajnerová et al.,
2014; Ledoux et al., 2014) report preclinical and clinical evidence
for brain correlates of cognitive deficits in schizophrenia. An inter-
esting hypothesis was presented by Nekovarova et al. (2014a) who
proposed a translation of findings from animal studies into clinical
symptoms of schizophrenia. Specifically, Higuchi et al. described
electrophysiological and neuropsychological evidence for cogni-
tive disruptions in subjects at-risk for schizophrenia (Sumiyoshi
et al., 2013b; Higuchi et al., 2014). Furthermore, Sumiyoshi et al.
(2013a) have provided a theory of a neural basis for atypical
antipsychotic drugs to improve cognition in schizophrenia.
Several lines of preclinical evidence on cognitive disturbances
are presented. Takashi et al. (2014) found the ability of tan-
dospirone, a 5-HT1A partial agonist, to alleviate aberrant lactate
production. Their observations point to a potentially novel thera-
peutic target for treating schizophrenia-related cognitive deficits.
Pei et al. (2014) report divergent phenotypes of neuregulin-1-
mutant mice, an animal model of schizophrenia, and the effect
of valproate, a mood stabilizer, to improve cognition. Kubík et al.
(2014) employed a pharmacological animal model of acute psy-
chosis using the NMDA receptor antagonist MK-801. They found
a selective deficit in the co-ordination of multiple informational
streams and contextual specificity of neuronal activity, measured
by the expression of immediate-early genes.
A totally different serotonergic model of schizophrenia is pre-
sented by Rambousek et al. (2014). The study shows effects of
psilocin, an active serotonergic hallucinogen of Psylocibe mush-
rooms, on the acquisition, retrieval, and consolidation of memory
in two spatial navigation tasks. Another three studies (Kristofikova
et al., 2013; Enkel et al., 2014; Petrasek et al., 2014) examined a very
promising model of schizophrenia based on transgenic rats with
reduced activity of Nogo-A (a protein inhibiting axonal growth).
These rats exert neurodevelopmental abnormalities, and disrup-
tions were found in their brain biochemistry, motivation, higher
cognitive functions, and circadian rhythms.
Another part was dedicated to AD. Wesierska et al. (2013) show
that memantine, a compound used to treat the early stages of
AD, improves working memory in a spatial memory task; inter-
estingly only after acute application. The next three papers are
clinical, Vlcˇek and Laczó (2014) review neural correlates and spa-
tial orientation changes in mild cognitive impairment and AD.
Urbanova et al. (2014) demonstrate an intriguing potential of
neurosonology as a non-invasive approach for detecting cere-
brovascular disruptions associated with AD, and Marciniak et al.
(2014) review beneficial changes in meditation on the cognitive
functions associated with aging and neurodegeneration.
Another section is dedicated to depression, which is also
accompanied by subtle cognitive deficits, although more pro-
nounced disruptions are seen in the mood and motivation. A
theory paper by Nekovarova et al. (2014b) discusses the relation
between depression and pain and raises an interesting question,
whether antidepressants may also act as analgesics. Holubova
et al. (2014) report an antidepressant effect of pregnanolone glu-
tamate, a newly patented steroid derivative previously shown to
exert neuroprotective activity and acting mainly via use-dependent
inhibition of NMDA receptors. The final part of the book deals
with OCD, epilepsy, and three cognition- and neuropsychiatric
disorder-related reviews. A report by Hatalova et al. (2014) uses
an animal model of OCD based on sensitization by quinpirole, a
D2-like receptor agonist, and suggests evidence for disrupted cog-
nitive flexibility tested in spatial memory, cognitive co-ordination,
and flexibility tasks. Evidence of cognitive flexibility in OCD in
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clinical studies yielded mixed results; however, this task (called
active place avoidance with reversal on an apparatus called a
Carousel) contains a time limitation (animals have to respond
within 1 min). Alterations in cognitive flexibility in this model are
seen even in an undrugged state in sensitized animals, strongly
corroborating the face validity of this particular model of OCD,
especially for cognition studies. A relatively novel phenomenon
is Internet addiction, which is the topic of another article by
Zhou et al. (2013), who examine error-related negativity poten-
tials in Internet-addicted subjects. Two preclinical papers from
the field of epileptology (both by Mikulecká et al., 2014a,b) report
delayed negative consequences of the postnatal administration of
clonazepam on cognitive and social behaviors. This has great sig-
nificance, since in some countries, clonazepam is used for treating
pediatric epileptic patients. These papers suggest that great cau-
tion should be used in these prescriptions. Finally, three reviews
provide an update for cognition, behavior, and neuropsychiatric
disorders; Stuchlik (2014) discusses memory in dynamic environ-
ments and its relation to synaptic plasticity. Takeuchi et al. (2014)
examined, for the first time, the effect of sleep on the organi-
zation of memory processes. Finally, Karatsoreos (2014) reviews
relationships between circadian rhythms and neuropsychiatric
disorders.
The Book provides an up-to-date review on the integration
of preclinical and clinical approaches to cognitive deficits in neu-
ropsychiatric disorders. Our edition is expected to give greater
insight into treatment options with higher benefit/risk ratios.
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